Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind59
Udgave nummer12
Sider (fra-til)1547-1551
Antal sider5
ISSN0284-186X
DOI
StatusUdgivet - dec. 2020

Citationsformater